{
  "id": 12625270,
  "title": "VivoSim Labs Celebrates Updated FDA Regulations Allowing Greater use of Non-Animal Testing Methods",
  "url": "https://urgent.news/2026/10/07/vivosim-labs-celebrates-updated-fda-regulations-allowing-greater-use",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-07T12:06:53.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/vivosim-labs-celebrates-updated-fda-regulations-allowing-greater-use-of-non-animal-testing-methods"
  },
  "original_language": "en",
  "account": null,
  "summary": "As the FDA opens the door to non-animal safety testing, VivoSim’s human-relevant models are already helping lower drug costs SAN DIEGO, Oct. 07, 2026 (GLOBE NEWSWIRE) — VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models for preclinical safety, today celebrated the U.S. […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}